A Long Term Safety Study of Degarelix in Patients With Prostate Cancer
Launched by FERRING PHARMACEUTICALS · Aug 26, 2009
Trial Information
Current as of June 07, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Completed any of the trials; FE 200486 CS27, CS28, CS30 or CS31
- Exclusion Criteria:
- • Discontinued any of the trials: FE 200486 CS27, CS28, CS30 or CS31
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a global biopharmaceutical company dedicated to the research, development, and commercialization of innovative therapies that address unmet medical needs in various therapeutic areas, including reproductive health, urology, and gastrointestinal disorders. With a strong commitment to advancing healthcare through scientific excellence and patient-centered solutions, Ferring leverages its extensive expertise in hormone-related treatments and personalized medicine. The company actively engages in clinical research to develop safe and effective therapies, striving to improve the quality of life for patients worldwide while maintaining a focus on ethical practices and collaboration in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Lyon, , France
Bruxelles, , Belgium
Napoli, , Italy
Vigo, , Spain
Lille, , France
Barcelona, , Spain
Sevilla, , Spain
Paris, , France
Villejuif, , France
Bilbao, , Spain
Amadora, , Portugal
Saint Priest En Jarez, , France
Saint Herblain Cedex, , France
Turnhout, , Belgium
Ancona, , Italy
Bologna, , Italy
Milano, , Italy
Milano, , Italy
Palermo, , Italy
Perugia, , Italy
Roma, , Italy
San Giovanni Rotondo, , Italy
Torino, , Italy
Coimbra, , Portugal
Lisboa, , Portugal
Porto, , Portugal
Göteborg, , Sweden
Göteborg, , Sweden
Helsingborg, , Sweden
Malmö, , Sweden
Södertälje, , Sweden
Uppsala, , Sweden
Madrid, , Spain
Besancon, , France
Bordeaux Cedex, , France
Caen, , France
Creteil, , France
Marseille, Cedex, , France
Montpellier, , France
Paris, , France
Perigueux, , France
Poitiers, , France
St Brieuc Cedex, , France
Strassbourg, , France
Toulon, , France
Toulouse, , France
Firenze, , Italy
Alcalá De Henares Madrid, , Spain
Alcorcon, , Spain
Barcelona, , Spain
Barcelona, , Spain
Madrid, , Spain
Majadahonda, , Spain
Manacor, , Spain
Oviedo, , Spain
Santiago De Compostela, , Spain
Valencia, , Spain
Ankara, , Turkey
Istanbul, , Turkey
Istanbul, , Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
Clinical Development Support
Study Director
Ferring Pharmaceuticals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials